Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Expected to Reach USD 47 Billion by 2034 with a CAGR of 3.6%

The Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market has seen significant attention due to the increasing prevalence of prostate-related conditions, particularly among the aging male population. Benign prostatic hyperplasia, a non-cancerous enlargement of the prostate gland, causes various urinary symptoms that severely affect the quality of life. As awareness grows regarding the importance of timely …